Board of Trustees

 

As a Danish commercial foundation, the LEO Foundation is fully independent of outside interests and has no owners or personal beneficiaries. The foundation is governed by a Board of Trustees consisting of 11 members. Seven members are elected in accordance with the Foundation’s charter, while four are representatives elected by the employees in LEO Pharma A/S in accordance with applicable law.  The daily management is carried out by the Foundation’s CEO, assisted by a small management team.

The board is subject to supervision by the Danish foundation authorities, who ensure that the board acts in accordance with applicable law and the foundation’s charter.

The composition of the Board reflects the qualifications and skills necessary for the LEO Foundation to best fulfil the objectives defined in our charter. Once a year, the board carries out a self-evaluation to determine the competencies needed on the board and to enhance the board’s performance and effectiveness in terms of collaboration, processes and meeting efficiency.

The members of the Board of Trustees of the LEO Foundation also make up the Board of Directors of the Foundation’s wholly-owned subsidiary, LEO Holding A/S. Both boards meet at least four times a year, and in addition hold an annual seminar to discuss and review strategies.

Matters related to overall strategies and the Foundation’s grant activities are handled in the LEO Foundation board, while matters related to investments and our active ownership of LEO Pharma are handled in the board of LEO Holding.

Lars Olsen

Chairman of the Board
MD, MBA

Elected to the Board of Trustees
2015 (re-elected 2017, end of term 2019)

Special skills
General management, R&D, sales and marketing

Born
1965

Background
Executive Vice President, Global Sales & Marketing, LEO Pharma
Executive Vice President, Research & Development, LEO Pharma

Additional positions
LEO Holding A/S, Chairman
LEO Foundation Grant Committee, Member

Appointed by authorities
No

Considered independent
No

Jens Bo Olesen

Vice Chairman of the Board
MSc Pharmacy, Dieu (Mannaz) VL

Elected to the Board of Trustees
2007 (re-elected 2017, end of term 2019)
Elected Vice Chairman in 2011

Special skills
General management, sales and marketing

Born
1951

Background
Executive Vice President, LEO Pharma
Vice President, Dumex A/S
Vice President, LEO Pharma
General Manager Middle East, LEO Pharma

Additional positions
LEO Holding A/S, Vice Chairman
LEO Foundation Grant Committee, Member

Appointed by authorities
No

Considered independent
No

Allan Carsten Dahl

Employee elected Board member
MSc Chemistry, PhD

Elected to the Board of Trustees
2015 (end of term 2018)

Special skills
Organic process R&D, CMC development

Born
1967

Background
Development Chemist, PharmaZell Denmark A/S
Development Chemist, GEA Pharmaceutical A/S
Development Chemist, H. Lundbeck A/S
Research and Development Chemist, Niels Clauson-Kaas A/S

Additional positions
LEO Holding A/S, Board member

Appointed by authorities
No

Considered independent
No

* Employee-elected member of the boards

Cristina Lage

Board member
MSc Economics

Elected to the Board of Trustees
2016 (re-elected 2017, end of term 2019)

Special skills
General and change management, investment and asset management, financial risk management

Born
1954

Background
CEO, Unipension
CEO, Nordea Invest
CEO, Nordea Liv og Pension
Secretary General, Social Liberal Party
CEO, TV2/ Danmark
CEO, Louisiana Museum of modern Art
Financial Director, ISS Scandinavia

Additional positions
LEO Holding A/S, Board member
LEO Pharma A/S, Board member
LEO Foundation Investment Committee, Chairman

Arbejdsmarkedets Erhvervssikring, Chairman of the Board
Det Obelske Familiefond, Board member
SEB Pension DK, Board member and Chairman audit committee
Den Berlingske Fond, Board member
C.L. Davids Fond, Board member
Nykredit, member of Board of Representatives

Appointed by authorities
No

Considered independent
Yes

Eivind Kolding

Board member
MA Law, admitted to the Danish High Court

Elected to the Board of Trustees
2017 (end of term 2019)

Special skills
General management, finance, law

Born
1959

Background
CEO, Novo A/S
CEO, Danske Bank A/S
Group CFO, later CEO A.P.Møller-Mærsk A/S
Lawyer, Bornstein & Grønborg

Additional positions
LEO Holding A/S, Board member
LEO Foundation Investment Committee, Member
Danish Ship Finance, Chairman
CASA Group, Chairman
NNIT, Board member
Axcelfuture, Advisory board member
The Boston Consulting Group, Senior Advisor
Kunstforeningen Gammel Strand, Chairman
BiQ ApS, Board member

Appointed by authorities
No

Considered independent
Yes

Ingelise Saunders

Board member
MSc Pharmacy

Elected to the Board of Trustees
2016 (re-elected 2017, end of term 2019)

Special skills
General management, biotech, Big Pharma sales and marketing, business development and drug development

Born
1949

Background
CEO, Action Pharma A/S
CEO, SLS Invest AB
CEO, Celltech Pharmaceuticals Ltd
Executive Vice President, NovoNordisk A/S

Additional positions
LEO Holding A/S, Board member
LEO Pharma A/S, Board member

Acesion Pharma ApS, Chairman
MinervaX Aps, Chairman

Appointed by authorities
No

Considered independent
Yes

Jannie Kogsbøll

Employee elected Board member
Process Assistant

Elected to the Board of Trustees
1998 (re-elected 2017, end of term 2018)

Special skills
Production, processes

Born
1962

Background
F Group A/S (Fona)

Additional positions
LEO Holding A/S, Board member
LEO Pharma A/S, Board member
Employee Union, treasurer

Appointed by authorities
No

Considered independent
No

Employee-elected member of the boards

John Mehlbye

Board member
BSc Production Engineering

Elected to the Board of Trustees
2008 (re-elected 2017, end of term 2019)

Special skills
General management, product supply

Born
1950

Background
Executive Vice President, LEO Pharma
Managing Director, Pantherplast A/S
Vice President, LEO Pharma
Director, Dumex A/S
Site Director, FDB
Technical Director, DANIDA (Lesotho)

Additional positions
LEO Holding A/S, Board member
LEO Foundation Investment Committee, Member

Østagergaard, Board member

Appointed by authorities
No

Considered independent
No

Lars Kjøller

Employee elected Board member
MSc (Library & Information Science), PhD (Molecular Biology)

Elected to the Board of Trustees
2017 (end of term 2018)

Special skills
R&D information search and analysis (patents, competitors, literature), Scientific Competitive Intelligence

Born
1967

Background
Senior Researcher, Copenhagen University Hospital (Rigshospitalet)
Post-doc researcher, University College London
Assistant Professor, University of Aarhus

Additional positions
LEO Holding A/S, Board member

Appointed by authorities
No

Considered independent
No

Employee-elected member of the boards

Lotte Hjortshøj Larsen

Employee elected Board member
Diploma Graduate

Elected to the Board of Trustees
2018 (end of term 2022)

Special skills
People, Culture, Administration

Born
1971

Background
Personal Assistant, LEO Pharma
Head of HR Administration, LEO Pharma
HR Coordinator, LEO Pharma
Project Manager, LEO Pharma

Additional positions
LEO Holding A/S, Board member

Appointed by authorities
No

Considered independent
No

Employee-elected member of the boards

Dr Peter Schwarz

Board member
Professor, MD, DMSci, Department of Endocrinology, Rigshospitalet & Institute of Clinical Medicine, Copenhagen University

Elected to the Board of Trustees
2017 (end of term 2019)

Special skills
Endocrinology, Medicine, Clinical Biochemistry

Born
1959

Background
Research Fellow, Harvard Medical School
Head of Department, Hvidovre Hospital
Professor, Glostrup Hospital

Additional positions
LEO Holding A/S, Board member
LEO Foundation Grant Committee, Chairman

Appointed by authorities
No

Considered independent
Yes